Myocardial revascularization in patients with transcatheter aortic valve implantation (TAVI) and endovascular repair of thoracic aorta
N. A. Mironov,
R. S. Polyakov,
S. T. Matskeplishvili,
L. I. Dyachuk,
D. V. Fettser,
M. A. Trukhanova,
A. O. Averkova,
N. A. Karanadze,
Y. E. Arutunova https://doi.org/10.33667/2078-5631-2022-9-27-30
Abstract
Transcatheter aortic valve implantation is the main treatment for severe aortic stenosis in patients with high surgical risks. There are undeniable advantages such as minimally invasive access, better portability in patients and decreased risk of postoperative complications compare to open surgery. Unfortunately, most aortic stenoses have the same etiology with coronary artery diseases and it necessitates invasive treatment. Cardiac artery catheterization and providing of stable instrument position are complications in post TAVI patients. It is not always possible to perform angioplasty from diagnostic radial access in post TAVI patient and there is an option of changing access to femoral to provide more safe and stable position of instruments during manipulation.
About the Authors
N. A. Mironov
Moscow State University n. a. M. V. Lomonosov
Russian Federation
Russian Federation
Mironov Nikita A., clinical intern for 2nd year at Dept of Internal Diseases of Faculty of Fundamental Medicine
Moscow
R. S. Polyakov
Moscow State University n. a. M. V. Lomonosov
Russian Federation
Russian Federation
Polyakov Roman S., DM Sci (habil.), head. of Dept of X-ray Surgical Methods of Diagnosis and Treatment of the Medical Research and Education Center
Moscow
S. T. Matskeplishvili
Moscow State University n. a. M. V. Lomonosov
Russian Federation
Russian Federation
Matskeplishvili Simon T., DM Sci (habil.), RAS corresponding member, deputy director of Medical Research and Education Centre
Moscow
L. I. Dyachuk
Moscow State University n. a. M. V. Lomonosov
Russian Federation
Russian Federation
Dyachuk Larisa I., PhD Med, head of Dept of Cardiology of Medical Research and Education Centre
IstinaResearcher ID (IRID): 262606324
Moscow
D. V. Fettser
Moscow State University n. a. M. V. Lomonosov
Russian Federation
Russian Federation
Fetzer Denis V., PhD, physician at Dept of X-ray Surgical Methods of Diagnosis and Treatment of Medical Research and Education Centre
IstinaResearcher ID (IRID): 391823608
Moscow
M. A. Trukhanova
Moscow State University n. a. M. V. Lomonosov
Russian Federation
Russian Federation
Trukhanova Maria A., physician of Intensive Care Unit of Medical Research and Education Centre
IstinaResearcher ID (IRID): 208247688
Moscow
A. O. Averkova
Moscow State University n. a. M. V. Lomonosov
Russian Federation
Russian Federation
Averkova Anastasia O., PhD Med, physician at Dept of Cardiology of Medical Research and Education Centre
Moscow
N. A. Karanadze
Moscow State University n. a. M. V. Lomonosov
Russian Federation
Russian Federation
Karanadze Nino A., physician at Dept of Cardiology of Medical Research and Education Centre
IstinaResearcher ID (IRID): 164636649
Moscow
Y. E. Arutunova
Moscow State University n. a. M. V. Lomonosov
Russian Federation
Russian Federation
Arutyunova Yana E., PhD Med, physician at Dept of Cardiology of Medical Research and Education Centre
IstinaResearcher ID (IRID): 18961172
Moscow
References
1. Bacigalupo L. A., Wigley J. C., Rosen G. P. Right Coronary Artery In-Stent Obstruction After Transcatheter Aortic Valve Implantation (TAVI). J Cardiothorac Vasc Anesth. 2019; (6): 1691–1695. https://doi.org/10.1053/j.jvca.2018.11.024
2. Combaret N., Bouchant M., Motreff P., Souteyrand G. TAVI and coronary revascularization (in French). Ann Cardiol Angeiol. 2019; (6): 423–428. https://doi.org/10.1016/j.ancard.2019.09.019
3. O’Sullivan C.J., Stefanini G. G., Stortecky S., Tüller D., Windecker S., Wenaweser P. Coronary revascularization and TAVI: before, during, after or never. Minerva Med. 2014; (6): 475–85.
4. Hecker F., Arsalan M., Kim W. K., Walther T. Transcatheter aortic valve implantation (TAVI) in 2018: recent advances and future development. Minerva Cardioangiol. 2018; (3): 314–328 https://doi.org/10.23736/S0026–4725.17.04532–7
5. Stefanini G. G., Panico C. CAD in TAVI patients: relevance of disease complexity. EuroIntervention: journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, 2015; (4). 373–375. https://doi.org/10.4244/EIJV11I4A76
6. López O. D., Avila-Carrillo A., González Ferreiro R., et al. Impact of Coronary Revascularization in Patients Who Underwent Transcatheter Aortic Valve Implantation. The American journal of cardiology, 2019; (6): 948–955. https://doi.org/10.1016/j.amjcard.2018.12.007
7. D’Ascenzo F., Verardi R., Visconti M., et al. Independent impact of extent of coronary artery disease and percutaneous revascularisation on 30-day and one-year mortality after TAVI: a meta-analysis of adjusted observational results. EuroIntervention. 2018; (11): 1169–1177. https://doi.org/10.4244/EIJ-D-18–00098
Review
For citations:
Mironov N.A., Polyakov R.S., Matskeplishvili S.T., Dyachuk L.I., Fettser D.V., Trukhanova M.A., Averkova A.O., Karanadze N.A., Arutunova Y.E. Myocardial revascularization in patients with transcatheter aortic valve implantation (TAVI) and endovascular repair of thoracic aorta. Medical alphabet. 2022;(9):27-30. (In Russ.) https://doi.org/10.33667/2078-5631-2022-9-27-30
Views:
362
Email this article 